Literature DB >> 17994885

Standardized platform for coregistration of nonconcurrent diffuse optical and magnetic resonance breast images obtained in different geometries.

Fred S Azar1, Kijoon Lee, Ali Khamene, Regine Choe, Alper Corlu, Soren D Konecky, Frank Sauer, Arjun G Yodh.   

Abstract

We present a novel methodology for combining breast image data obtained at different times, in different geometries, and by different techniques. We combine data based on diffuse optical tomography (DOT) and magnetic resonance imaging (MRI). The software platform integrates advanced multimodal registration and segmentation algorithms, requires minimal user experience, and employs computationally efficient techniques. The resulting superposed 3-D tomographs facilitate tissue analyses based on structural and functional data derived from both modalities, and readily permit enhancement of DOT data reconstruction using MRI-derived a-priori structural information. We demonstrate the multimodal registration method using a simulated phantom, and we present initial patient studies that confirm that tumorous regions in a patient breast found by both imaging modalities exhibit significantly higher total hemoglobin concentration (THC) than surrounding normal tissues. The average THC in the tumorous regions is one to three standard deviations larger than the overall breast average THC for all patients.

Entities:  

Mesh:

Year:  2007        PMID: 17994885     DOI: 10.1117/1.2798630

Source DB:  PubMed          Journal:  J Biomed Opt        ISSN: 1083-3668            Impact factor:   3.170


  15 in total

Review 1.  Implicit and explicit prior information in near-infrared spectral imaging: accuracy, quantification and diagnostic value.

Authors:  Brian W Pogue; Scott C Davis; Frederic Leblond; Michael A Mastanduno; Hamid Dehghani; Keith D Paulsen
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2011-11-28       Impact factor: 4.226

2.  NIRViz: 3D visualization software for multimodality optical imaging using visualization toolkit (VTK) and insight segmentation toolkit (ITK).

Authors:  Senate Johannes Taka; Subhadra Srinivasan
Journal:  J Digit Imaging       Date:  2011-12       Impact factor: 4.056

3.  Optical mammography: Diffuse optical imaging of breast cancer.

Authors:  Kijoon Lee
Journal:  World J Clin Oncol       Date:  2011-01-10

4.  Diffuse Optics for Tissue Monitoring and Tomography.

Authors:  T Durduran; R Choe; W B Baker; A G Yodh
Journal:  Rep Prog Phys       Date:  2010-07

5.  Diffuse optical tomography reconstruction method using ultrasound images as prior for regularization matrix.

Authors:  Murad Althobaiti; Hamed Vavadi; Quing Zhu
Journal:  J Biomed Opt       Date:  2017-02-01       Impact factor: 3.170

6.  Image-guided near infrared spectroscopy using boundary element method: phantom validation.

Authors:  Subhadra Srinivasan; Colin Carpenter; Brian W Pogue; Keith D Paulsen
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2009-02-20

7.  Two step imaging reconstruction using truncated pseudoinverse as a preliminary estimate in ultrasound guided diffuse optical tomography.

Authors:  K M Shihab Uddin; Atahar Mostafa; Mark Anastasio; Quing Zhu
Journal:  Biomed Opt Express       Date:  2017-11-08       Impact factor: 3.732

Review 8.  Review of quantitative multiscale imaging of breast cancer.

Authors:  Michael A Pinkert; Lonie R Salkowski; Patricia J Keely; Timothy J Hall; Walter F Block; Kevin W Eliceiri
Journal:  J Med Imaging (Bellingham)       Date:  2018-01-22

9.  Comparison of diffuse optical tomography of human breast with whole-body and breast-only positron emission tomography.

Authors:  Soren D Konecky; Regine Choe; Alper Corlu; Kijoon Lee; Rony Wiener; Shyam M Srinivas; Janet R Saffer; Richard Freifelder; Joel S Karp; Nassim Hajjioui; Fred Azar; Arjun G Yodh
Journal:  Med Phys       Date:  2008-02       Impact factor: 4.071

10.  Diffuse Optical Monitoring of the Neoadjuvant Breast Cancer Therapy.

Authors:  Regine Choe; Turgut Durduran
Journal:  IEEE J Sel Top Quantum Electron       Date:  2011-12-02       Impact factor: 4.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.